Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome

BACKGROUND: Rifaximin is a minimally absorbed antibiotic with high luminal activity, used to treat various gastrointestinal diseases. Although rifaximin has been proposed as first line treatment for small intestinal bacterial overgrowth (SIBO), few data are available regarding its efficacy in non-IB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boltin, Doron, Perets, Tsachi Tsadok, Shporn, Einav, Aizic, Shoshana, Levy, Sigal, Niv, Yaron, Dickman, Ram
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201689/
https://ncbi.nlm.nih.gov/pubmed/25319626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-014-0049-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados